TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE B-

NCT07820943: Clinical, Subjective, and Instrumental Evaluation of Dermatological Acceptability and Efficacy in Improving Dryness, Hydration, and Skin Barrier Function in Participants With Xerosis

Sponsor: Brainfarma Industria Química e Farmacêutica S/A · Phase: PHASE2 · Area: DERMATOLOGY_AESTHETIC · Target Enrollment: 22 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$1,290,000

Rescue Site Savings

+$851,400

Unlock Full NCT07820943 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07820943 Rescue Dossier →